Information Library
Results for: White Papers - Lower portfolio & investment risks
To learn more about Quintiles’ services, you may broaden or narrow your search by selecting the topics at left.
- Sort by:
- Recently Added
- Title
-
Partnering to Maximize Rewards in Pharmerging Markets
September 15, 2011
In the past few years so-called “pharmerging” markets have been heralded as the hottest growth area for biopharmaceutical drugs. With large populations, growing disposable income and unmet medical needs, these markets have seen doubledigit growth rates in pharmaceutical spending. -
The New Health Alliance
January 10, 2011
Biopharmaceutical companies must explore alternative strategic alliances that meet the needs of the New Health and produce medicines that demonstrate value to the entire constellation of stakeholders. -
Managing Pharmacovigilance as a Business
July 28, 2010
The three steps required to develop a strategic approach to global capacity management. -
Rebalancing Risk to Transform R&D
June 3, 2009
A strategic approach to re-balancing the main components of biopharma company risk: portfolio, operational and resource.
Page 1 of 1 (4 results)
